This is notably highlighted by the use of anti-TNFα kinoid in a phase-2 trial in rheumatoid arthritis (ClinicalTrials.gov identifier NCT01040715) and Crohn’s disease (ClinicalTrials.gov identifier NCT01291810). The gene discussed is TNF; the disease is Crohn disease.